These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 13111954)

  • 1. Resistance acquired by the Koch bacillus during isoniazid therapy of pulmonary tuberculosis.
    DUFOURT A; BRUN J; VIALLIER J; SERRE H
    Poumon; 1953 Apr; 9(4):219-30. PubMed ID: 13111954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subtilis therapy in pulmonary diseases. I. Bacillus subtilis in the treatment of pulmonary tuberculosis].
    Pham Ngoc Thach
    Sem Ther; 1964 Dec; 40(10):607-13. PubMed ID: 4964177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of cyanacetic acid hydrazide in anti-tuberculosis therapy on indices of organic resistance; clinico-functional studies].
    SISTI MA; SCODITTI G
    Lotta Tuberc; 1957 Sep; 27(9):760-2 passim. PubMed ID: 13515423
    [No Abstract]   [Full Text] [Related]  

  • 4. Cycloserine and isoniazid in reduced dosage combination in the therapy of pulmonary tuberculosis.
    ROBITZEK EH; NENASHEV PK
    Antibiot Annu; 1956-1957; ():431-6. PubMed ID: 13425417
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems connected with combination therapy of pulmonary tuberculosis; bacteriological results of monotherapy with isoniazid & combination therapy with isoniazid & streptomycin].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1958; 119(4):371-5; discussion 375-88. PubMed ID: 13607372
    [No Abstract]   [Full Text] [Related]  

  • 6. [PIRAZINAMIDE-ISONIAZID combined therapy for pulmonary tuberculosis; original treatment in cases with unified background factors. I].
    Kekkaku; 1957 Aug; 32(8):431-5. PubMed ID: 13482096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Origin of acquired drug resistance in patients during pulmonary tuberculosis therapy].
    DELOFF L
    Pol Tyg Lek (Wars); 1959 May; 14(20):902-7. PubMed ID: 13674968
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of Bac. subtilis for the treatment of pulmonary tuberculosis and other pneumopathies].
    Fam NGOK TKHAK ; Le VAN TKHO ; Koan DING TRUNG ; Hguen VAN GUA ; Buu GUNG ; Nguen KIM PKHAT
    Sov Med; 1965 Dec; 28(12):53-7. PubMed ID: 4959833
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-biological observations on the use of verazide in the therapy of pulmonary tuberculosis].
    BARBOLINI G; LOSCHI GC
    Clin Ter; 1961 Mar; 20():253-73. PubMed ID: 13686822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of pulmonary tuberculosis with special reference to new results of resistance & virulence research].
    LANGER R
    Med Monatsschr; 1957 Jun; 11(6):376-9. PubMed ID: 13451122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cortisone and derivatives in therapy of pulmonary tuberculosis; case reports].
    GOTI F; VERCELLINO A
    Minerva Med; 1957 Sep; 48(77):3086-92. PubMed ID: 13483330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allergic edema due to isoniazid therapy of pulmonary tuberculosis].
    BUCHWALD G
    Z Tuberk; 1957; 110(3-4):152-5. PubMed ID: 13531547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical study of the resistance of Koch's bacillus to antibiotics during pulmonary tuberculosis].
    DUBOIS-VERLIERE
    Sem Hop; 1954 Aug 10-14; 30(50-51):3006-8. PubMed ID: 13195754
    [No Abstract]   [Full Text] [Related]  

  • 14. [Failures in tuberculosis therapy and supplementary antibiotic therapy].
    RABINO A; TORREGROSSA O
    Minerva Med; 1957 Sep; 48(77):3113-4. PubMed ID: 13483336
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiological significance of isoniazid resistance in open tuberculosis].
    BIERSCHENK H
    Z Tuberk; 1958; 111(3-4):159-64. PubMed ID: 13604791
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS; Le HQ; Rikleen D; Davidson P
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results of combined phenylbutazone & isoniazid therapy in pulmonary tuberculosis].
    POZZI G; SCOCCIA S; LEONARDI G
    Policlinico Prat; 1958 Jan; 65(3):83-8. PubMed ID: 13553815
    [No Abstract]   [Full Text] [Related]  

  • 18. [Continuous clinical & bacteriological studies on results of prolonged isoniazid & PAS therapy of pulmonary tuberculosis].
    HELWEG-LARSEN P; RASMUSSEN KN
    Nord Med; 1957 Sep; 58(38):1409-10. PubMed ID: 13484025
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic application of a preparation obtained from mechanically disintegrated tubercle bacillus. II. A satisfactory treatment of minimal pulmonary tuberculosis.
    NAGAO S; KAZAMA Y; TODA Y
    Ann Tuberc; 1955 Apr; 5(3):106-20. PubMed ID: 13239088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Data on clinical resistance].
    FAUSZT I
    Tuberkulozis; 1957; 10(1-2):33-5. PubMed ID: 13455834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.